发明授权
- 专利标题： Pyrazolopyrimidines as cyclin dependent kinase inhibitors
- 专利标题（中）： 吡唑并嘧啶类作为细胞周期蛋白依赖性激酶抑制剂
-
申请号： US11779050申请日： 2007-07-17
-
公开(公告)号： US07511049B2公开(公告)日： 2009-03-31
- 发明人: Timothy J. Guzi , Kamil Paruch , Michael P. Dwyer , Ronald J. Doll , Viyyoor M. Girijavallabhan , Lawrence W. Dillard , Vinh D. Tran , Zhenmin He , Ray Anthony James , Haengsoon Park
- 申请人： Timothy J. Guzi , Kamil Paruch , Michael P. Dwyer , Ronald J. Doll , Viyyoor M. Girijavallabhan , Lawrence W. Dillard , Vinh D. Tran , Zhenmin He , Ray Anthony James , Haengsoon Park
- 申请人地址： US NJ Kenilworth US NJ Cranbury
- 专利权人： Schering Corporation,Pharmacopeia, Inc.
- 当前专利权人： Schering Corporation,Pharmacopeia, Inc.
- 当前专利权人地址： US NJ Kenilworth US NJ Cranbury
- 代理商 Palaiyur S. Kalyanaraman; Serena Farquharson-Torres
- 主分类号： A61K31/519
- IPC分类号： A61K31/519 ; A61P35/00 ; C07D487/04
摘要：
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
公开/授权文献
信息查询
IPC分类:
